Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG – RAPID Trial): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To determine the effect of therapeutic anticoagulation, with low molecular weight heparin (LMWH) or unfractionated heparin (UFH, high dose nomogram), compared to standard care in hospitalized patients admitted for COVID-19 with an elevated D-dimer on the composite outcome of intensive ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Sholzberg, Michelle, Tang, Grace H., Negri, Elnara, Rahhal, Hassan, Kreuziger, Lisa Baumann, Pompilio, Carlos E., James, Paula, Fralick, Michael, AlHamzah, Musaad, Alomran, Faris, Tseng, Eric, Lim, Gloria, Lillicrap, David, Carrier, Marc, Áinle, Fionnuala Ní, Beckett, Andrew, da Costa, Bruno R., Thorpe, Kevin, Middeldorp, Saskia, Lee, Agnes, Cushman, Mary, Jüni, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943934/
https://www.ncbi.nlm.nih.gov/pubmed/33691765
http://dx.doi.org/10.1186/s13063-021-05076-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943934/
https://www.ncbi.nlm.nih.gov/pubmed/33691765
http://dx.doi.org/10.1186/s13063-021-05076-0

Ejemplares similares